Instruments And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.21 M
as on 24-10-2024
- Company Age 66 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.90 Cr
as on 24-10-2024
- Satisfied Charges ₹ 3.84 Cr
as on 24-10-2024
- Revenue 51.31%
(FY 2023)
- Profit 183.71%
(FY 2023)
- Ebitda 49.32%
(FY 2023)
- Net Worth 10.27%
(FY 2023)
- Total Assets 2.08%
(FY 2023)
About Instruments And Chemicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.21 M.
The company currently has active open charges totaling ₹22.90 Cr. The company has closed loans amounting to ₹3.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Jain and Karan Jolly serve as directors at the Company.
- CIN/LLPIN
U74899HR1958PTC001286
- Company No.
001286
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 1958
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Ambala, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Instruments And Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Jain  | Whole-Time Director | 29-Mar-1994 | Current |
| Karan Jolly | Director | 31-Jan-2012 | Current |
Financial Performance and Corporate Structure Insights of Instruments And Chemicals.
Instruments And Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 51.31% increase. The company also saw a substantial improvement in profitability, with a 183.71% increase in profit. The company's net worth Soared by an impressive increase of 10.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Instruments And Chemicals?
In 2023, Instruments And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2024 | ₹0.51 M | Open |
Others Creation Date: 19 Jul 2022 | ₹1.73 Cr | Open |
Others Creation Date: 28 Jun 2022 | ₹13.10 Cr | Open |
How Many Employees Work at Instruments And Chemicals?
Instruments And Chemicals has a workforce of 45 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Instruments And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Instruments And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
